Credit Suisse’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$11 | – | 3615 |
|
|
2022
Q4 | $11 | Sell |
1
-12,096
| -100% | -$133K | ﹤0.01% | 3713 |
|
|
2022
Q3 | $143K | Buy |
12,097
+90
| +0.7% | +$1.06K | ﹤0.01% | 3324 |
|
|
2022
Q2 | $136K | Sell |
12,007
-1,659
| -12% | -$18.8K | ﹤0.01% | 3438 |
|
|
2022
Q1 | $409K | Buy |
13,666
+891
| +7% | +$26.7K | ﹤0.01% | 3067 |
|
|
2021
Q4 | $338K | Buy |
12,775
+377
| +3% | +$9.98K | ﹤0.01% | 3249 |
|
|
2021
Q3 | $450K | Buy |
12,398
+1,869
| +18% | +$67.8K | ﹤0.01% | 3051 |
|
|
2021
Q2 | $458K | Sell |
10,529
-5,853
| -36% | -$255K | ﹤0.01% | 3071 |
|
|
2021
Q1 | $561K | Sell |
16,382
-17,286
| -51% | -$592K | ﹤0.01% | 2888 |
|
|
2020
Q4 | $1.18M | Sell |
33,668
-4,655
| -12% | -$163K | ﹤0.01% | 2476 |
|
|
2020
Q3 | $919K | Buy |
38,323
+22,180
| +137% | +$532K | ﹤0.01% | 2324 |
|
|
2020
Q2 | $296K | Buy |
16,143
+241
| +2% | +$4.42K | ﹤0.01% | 2955 |
|
|
2020
Q1 | $247K | Sell |
15,902
-15,984
| -50% | -$248K | ﹤0.01% | 2937 |
|
|
2019
Q4 | $683K | Buy |
31,886
+1,224
| +4% | +$26.2K | ﹤0.01% | 2750 |
|
|
2019
Q3 | $574K | Buy |
30,662
+4,990
| +19% | +$93.4K | ﹤0.01% | 2723 |
|
|
2019
Q2 | $669K | Buy |
25,672
+8,226
| +47% | +$214K | ﹤0.01% | 2612 |
|
|
2019
Q1 | $448K | Sell |
17,446
-4,335
| -20% | -$111K | ﹤0.01% | 2832 |
|
|
2018
Q4 | $501K | Buy |
21,781
+5,816
| +36% | +$134K | ﹤0.01% | 2739 |
|
|
2018
Q3 | $513K | Sell |
15,965
-72,204
| -82% | -$2.32M | ﹤0.01% | 2820 |
|
|
2018
Q2 | $2.5M | Buy |
88,169
+71,914
| +442% | +$2.04M | ﹤0.01% | 1909 |
|
|
2018
Q1 | $575K | Sell |
16,255
-4,820
| -23% | -$171K | ﹤0.01% | 2885 |
|
|
2017
Q4 | $817K | Buy |
21,075
+12,272
| +139% | +$476K | ﹤0.01% | 2668 |
|
|
2017
Q3 | $223K | Sell |
8,803
-3,495
| -28% | -$88.5K | ﹤0.01% | 3400 |
|
|
2017
Q2 | $335K | Sell |
12,298
-12,350
| -50% | -$336K | ﹤0.01% | 3015 |
|
|
2017
Q1 | $816K | Sell |
24,648
-40,331
| -62% | -$1.34M | ﹤0.01% | 2659 |
|
|
2016
Q4 | $1.55M | Buy |
64,979
+44,609
| +219% | +$1.06M | ﹤0.01% | 2344 |
|
|
2016
Q3 | $748K | Buy |
20,370
+9,410
| +86% | +$346K | ﹤0.01% | 2862 |
|
|
2016
Q2 | $244K | Buy |
10,960
+7,308
| +200% | +$163K | ﹤0.01% | 3478 |
|
|
2016
Q1 | $76K | Sell |
3,652
-10,400
| -74% | -$216K | ﹤0.01% | 3561 |
|
|
2015
Q4 | $426K | Buy |
14,052
+8,520
| +154% | +$258K | ﹤0.01% | 3277 |
|
|
2015
Q3 | $136K | Buy |
5,532
+11
| +0.2% | +$270 | ﹤0.01% | 3831 |
|
|
2015
Q2 | $177K | Buy |
5,521
+1,761
| +47% | +$56.5K | ﹤0.01% | 3975 |
|
|
2015
Q1 | $134K | Sell |
3,760
-570
| -13% | -$20.3K | ﹤0.01% | 3891 |
|
|
2014
Q4 | $98K | Sell |
4,330
-7,919
| -65% | -$179K | ﹤0.01% | 4057 |
|
|
2014
Q3 | $237K | Buy |
12,249
+6,282
| +105% | +$122K | ﹤0.01% | 3659 |
|
|
2014
Q2 | $217K | Sell |
5,967
-6,496
| -52% | -$236K | ﹤0.01% | 3877 |
|
|
2014
Q1 | $484K | Sell |
12,463
-9,659
| -44% | -$375K | ﹤0.01% | 3371 |
|
|
2013
Q4 | $631K | Buy |
22,122
+12,247
| +124% | +$349K | ﹤0.01% | 3211 |
|
|
2013
Q3 | $354K | Sell |
9,875
-23,344
| -70% | -$837K | ﹤0.01% | 3272 |
|
|
2013
Q2 | $1.11M | Buy |
+33,219
| New | +$1.11M | ﹤0.01% | 2356 |
|